American Academy of Private Physicians (AAPP) Selects Itamar-Medical’s EndoPAT™ and WatchPAT™ Products to Promote Patient

  American Academy of Private Physicians (AAPP) Selects Itamar-Medical’s
  EndoPAT™ and WatchPAT™ Products to Promote Patient Wellness

Business Wire

CAESAREA, Israel -- March 11, 2013

Itamar-Medical (TASE: ITMR), the world's leader of noninvasive technology for
diagnosis of cardiovascular health, announced today that it has an agreement
with the American Academy of Private Physicians (AAPP) to include Itamar's
EndoPAT & WatchPAT testing to the innovative suite of diagnostics technologies
offered by AAPP physicians to their patients.

As pioneers in the new area of concierge medicine and private healthcare, AAPP
members are focused on improving the quality of patient care, strengthening
the bond between patients and their physicians, empowering patients as health
care consumers; and reducing the cost of health care through diligent
management of emerging health risks and chronic conditions.

By including EndoPAT and WatchPAT in AAPP's portfolio, member physicians will
be able to add a vital dimension to cardiac and sleep medicine management by
allowing early identification and treatment of endothelial dysfunction (a
precursor of cardiovascular disease) and sleep apnea (a major factor in
cardiovascular risk that has been shown to increase driving fatalities,
hypertension, atherosclerosis, and obesity). This will improve the quality of
patient care strengthening the bond between patients and their physician.

"One of our goals is to identify technologies that truly add value to our
members' practices as they strive to provide state-of-the-art health
management to their patients. I believe we have found two devices from one
highly innovative company that will enable our members to continue to lead
their communities in the early identification and management of cardiovascular
risk," said Tom Blue, Executive Director, American Academy of Private
Physicians (AAPP).

“We are pleased to have developed a program that provides members of the AAPP
and their patients access to these latest breakthrough technologies, advancing
wellness through these critical measures of health,” said Marvin Slosman,
President, Itamar-Medical Inc. USA.

AAPP physicians will be introduced and trained on the EndoPAT and WatchPAT
devices during their annual members’ conference on March 22-23rd, 2013 in Palm
Springs, CA.

About AAPP: The American Academy of Private Physicians (AAPP) is a nonprofit
organization founded in 2003 for the purpose of supporting and fueling the
growth of medical practices that provide “concierge” and other forms of
personalized, value-based medical care.

About Itamar-Medical: Itamar-Medical (TASE: ITMR) is a medical technology
company developing state-of-the-art biomedical products based on a proprietary
signal for non-invasive, early detection of heart disease & obstructive sleep

About WatchPAT™: The convenient, portable sleep apnea diagnostic device
installed by the patient in their own home -- all without cumbersome nasal
cannulas or belts.

About EndoPAT™: The only noninvasive, FDA-cleared device diagnosing
endothelial function via an arterial stress test to the cardiovascular system
providing an early indicator of cardiovascular disease. This 15-minute,
office-based diagnostic is used by many hospitals around the nation such as
Mayo Clinic, Mount Sinai New York, Cedars-Sinai Los Angeles, Johns Hopkins
University, and has been incorporated into the Framingham Heart Study during
the past 8 years.


Triwaks + Sasi + Aharoni
Ortal Ganot, senior account executive
Press spacebar to pause and continue. Press esc to stop.